Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Clinical trial NCT07321912 · RECRUITING

Trial details

NCT number: NCT07321912
Sponsor: Milton S. Hershey Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Ewing Sarcoma

Start date: 2026-06-05
Primary completion: 2031-06-01
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.